ATTD-ASIA is a groundbreaking expansion of ATTD – the leading international meeting point where clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and people with diabetes assemble with the aim of sharing knowledge and developing collaborations.

Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as digital clinics, decision support systems/advisors, big data and artificial intelligence-based decision support systems, glucose sensors, closed-and open-loop systems, artificial pancreas, devices for diabetic prevention, new insulins and new medications, insulin pumps and many more.

*Subject to changes

Session Topics**

• CGM AS THE CORNERSTONE OF DIABETES MANAGEMENT
• CGM IN PRE-T2D AND EARLY T2D
• CLINICAL DECISION SUPPORT SYSTEMS (CDSS) AND APPS
• CLOSED LOOP
• COMBINED GLP1RA AND SGLT2
• COPING WITH OBESITY WITH OR WITHOUT DIABETES
• DIABETES & CVD
• DIABETES & PREGNANCY
• IMPLEMENTING NEW TECHNOLOGIES IN DIABETES MANAGEMENT
• INCRETINS AND THE REMISSION OF DIABETES
• LIFESTYLE MODIFICATIONS RELEVANT TO ASIA (DIET AND EXERCISE OPTIONS)
• MANAGING T2D IN PRIMARY CARE
• PEDIATRIC OBESITY AND DIABETES
• PRE T2D
• PRE-STAGE 3 T1D
• SCREENING PROGRAM AND PREVENTION T1D
• THERAPEUTIC CHOICES FOR OBESITY AND T2D
• TIGHT GLYCEMIC CONTROL
• TRAINING DIABETES TECHNOLOGISTS
• WEEKLY INSULIN

**Topic list as of 21 April 2024